Triazolopyridines for the treatment of thrombosis disorders
    2.
    发明授权
    Triazolopyridines for the treatment of thrombosis disorders 有权
    用于治疗血栓形成障碍的三唑并吡啶类

    公开(公告)号:US06303625B1

    公开(公告)日:2001-10-16

    申请号:US09354032

    申请日:1999-07-15

    IPC分类号: A61K31437

    CPC分类号: C07D471/04 C07D211/34

    摘要: The invention is directed to novel triazolopyridine derivatives which are useful as antagonists of GPIIb/IIIa. Pharmaceutical compositions comprising the triazolopyridine derivatives of the present invention, methods of treating conditions mediated by GPIIb/IIIa (e.g., methods for treating platelet-mediated thrombotic disorders) along with processes for making the compounds and novel intermediates are also disclosed.

    摘要翻译: 本发明涉及可用作GPIIb / IIIa的拮抗剂的新型三唑并吡啶衍生物。 还公开了包含本发明的三唑并吡啶衍生物的药物组合物,治疗由GPIIb / IIIa介导的病症的方法(例如,用于治疗血小板介导的血栓形成障碍的方法)以及制备该化合物和新型中间体的方法。